Eliminating an Old Adversary
In some regions—notably Africa—malaria is placing a heavier burden on individuals and societies than ever before. The foundation is funding projects that promise to decrease the devastation caused by malaria, and that may one day eradicate the disease.
We support efforts to:
Discover safe, effective, and affordable malaria vaccines
Develop methods to control mosquitoes that transmit malaria
Find new drugs to treat the disease
Ensure access to new drugs and vaccines
Expand the use of existing tools to control malaria
Build support among leaders for malaria research and control
In the 1960s, malaria was eliminated in several regions of the world. But where the disease persists—primarily in sub-Saharan Africa—health officials are noting the emergence of strains of the disease that are resistant to existing drugs. In addition, common insecticides used to control malaria-transmitting mosquitoes are beginning to fail. New efforts to address these challenges are underway.
Want to open your eyes to what is really going on here?
"In order to usher in synthetic biology and gain public approval, the initial showcased project is to develop a synthetic form of artemisinin, a molecule produced by the Wormwood plant that naturally grows in Southeast Asia. While artemisinin is a very cheap remedy for malaria, synthetic biologists claim it is still costly (estimated cost of $1 billion to supply 70% of malaria victims worldwide), so they want to make it synthetically.
The Bill & Melinda Gates Foundation has released a $42.5 million grant to produce synthetic artemisinin. But this is not true synthetic biology. They would be creating the same molecule. It’s a covert way of gaining public acceptance for things to come under the banner of synthetic biology. Furthermore, the Bill & Melinda Gates Foundation is looking more like a non-profit front for R&D of vaccines and medicines that will eventually make billions of dollars on a worldwide scale."